Annelies Verbon Selected Research

Aspergillosis

9/2018	The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol.
7/2015	Aerosolised liposomal amphotericin B to prevent aspergillosis in acute myeloid leukaemia: Efficacy and cost effectiveness in real-life.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annelies Verbon Research Topics

Disease

32	Infections 08/2023 - 08/2002
11	Mycetoma 05/2024 - 01/2020
9	HIV Infections (HIV Infection) 10/2023 - 04/2002
6	Acquired Immunodeficiency Syndrome (AIDS) 11/2022 - 04/2007
5	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 10/2007
5	Legionnaires' Disease (Legionnaire's Disease) 01/2018 - 08/2002
5	Sepsis (Septicemia) 10/2013 - 07/2009
4	Tuberculosis (Tuberculoses) 01/2017 - 01/2002
4	Pneumonia (Pneumonitis) 12/2004 - 08/2002
3	COVID-19 11/2022 - 01/2020
3	Fibrosis (Cirrhosis) 01/2022 - 01/2019
3	Inflammation (Inflammations) 01/2020 - 10/2019
3	Neutropenia 02/2016 - 01/2014
3	Abscess 01/2014 - 01/2013
3	Endotoxemia 07/2003 - 04/2002
2	Viremia 10/2023 - 01/2019
2	Malaria 01/2020 - 12/2016
2	Communicable Diseases (Infectious Diseases) 11/2019 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 04/2015
2	Aspergillosis 09/2018 - 07/2015
2	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2016 - 11/2013
2	Dyslipidemias (Dyslipidemia) 04/2015 - 01/2014
2	Diverticulitis 01/2013 - 01/2013
1	Bacterial Pneumonia 11/2022
1	Hyperthermia 12/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Acute Lung Injury 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Invasive Fungal Infections 01/2020
1	Meningoencephalitis 01/2020
1	Persistent Infection 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2018
1	Peritonitis 05/2018

Drug/Important Bio-Agent (IBA)

18	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2011
5	CytokinesIBA 01/2020 - 08/2002
4	Itraconazole (Sporanox)FDA LinkGeneric 10/2023 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2009
4	Antifungal AgentsIBA 06/2022 - 01/2020
4	Inosine TriphosphataseIBA 01/2018 - 01/2012
3	ER 30346 (ravuconazole)IBA 12/2022 - 01/2022
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2019
3	AntigensIBA 11/2019 - 12/2002
2	AzolesIBA 10/2023 - 09/2018
2	GlucansIBA 10/2023 - 04/2023
2	NucleosidesIBA 10/2023 - 01/2014
2	Reverse Transcriptase InhibitorsIBA 10/2023 - 01/2014
2	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2023 - 01/2002
2	Melanins (Melanin)IBA 02/2022 - 01/2021
2	olorofimIBA 01/2022 - 01/2020
2	CarbamatesIBA 01/2022 - 01/2022
2	benzimidazoleIBA 01/2022 - 01/2022
2	Viral RNAIBA 11/2021 - 01/2021
2	Interleukin-12 (IL 12)IBA 12/2019 - 08/2012
2	dolutegravirIBA 10/2019 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 11/2005
2	Toll-Like Receptor 4IBA 02/2005 - 08/2002
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2004 - 11/2003
2	LipopolysaccharidesIBA 08/2002 - 04/2002
1	resazurinIBA 05/2024
1	APX001AIBA 11/2023
1	IntegrasesIBA 10/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2023
1	polyglucosanIBA 04/2023
1	Indicators and Reagents (Reagents)IBA 11/2022
1	luliconazoleIBA 06/2022
1	latoconazole (lanoconazole)IBA 06/2022
1	Terbinafine (Lamisil)FDA LinkGeneric 01/2022
1	FenbendazoleIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	Neutralizing AntibodiesIBA 11/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	Valsartan (Vals)FDA Link 01/2020
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2020
1	Angiotensin IIIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 11/2019
1	AerosolsIBA 11/2019
1	LipidsIBA 10/2019
1	abacavir (Ziagen)FDA Link 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	InterferonsIBA 01/2019
1	Biogenic Amines (Biogenic Amine)IBA 11/2018
1	Tryptophan (L-Tryptophan)FDA Link 11/2018
1	Triglycerides (Triacylglycerol)IBA 11/2018
1	NitrogenIBA 11/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2018
1	SphingomyelinsIBA 11/2018
1	QuinolonesIBA 05/2018
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2018
1	ametantrone (HAQ)IBA 01/2018
1	Bacterial DNAIBA 01/2018

Therapy/Procedure

20	Therapeutics 10/2023 - 12/2002
10	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 07/2009
3	Art Therapy 11/2022 - 01/2020
1	Continuity of Patient Care 11/2022
1	Treatment Delay 01/2019
1	Antibiotic Prophylaxis 05/2018